These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53 related articles for article (PubMed ID: 19729934)
1. Reduction of arteriosclerotic nanoplaque formation and size by n-3 fatty acids in patients after valvular defect operation. Koppe C; Rodríguez M; Winkler K; Pietzsch J; Neumann K; Hiemann NE; Hetzer R; Malmsten M; Siegel G Forsch Komplementmed; 2009 Aug; 16(4):237-45. PubMed ID: 19729934 [TBL] [Abstract][Full Text] [Related]
2. Reduction of atherosclerotic nanoplaque formation and size by Ginkgo biloba (EGb 761) in cardiovascular high-risk patients. Rodríguez M; Ringstad L; Schäfer P; Just S; Hofer HW; Malmsten M; Siegel G Atherosclerosis; 2007 Jun; 192(2):438-44. PubMed ID: 17397850 [TBL] [Abstract][Full Text] [Related]
3. The effect of garlic on arteriosclerotic nanoplaque formation and size. Siegel G; Malmsten M; Pietzsch J; Schmidt A; Buddecke E; Michel F; Ploch M; Schneider W Phytomedicine; 2004 Jan; 11(1):24-35. PubMed ID: 14971718 [TBL] [Abstract][Full Text] [Related]
4. Biosensing of arteriosclerotic nanoplaque formation and interaction with an HMG-CoA reductase inhibitor. Abletshauser C; Klüssendorf D; Schmidt A; Winkler K; März W; Buddecke E; Malmsten M; Siegel G Acta Physiol Scand; 2002 Oct; 176(2):131-45. PubMed ID: 12354173 [TBL] [Abstract][Full Text] [Related]
5. The effect of an HMG-CoA reductase inhibitor on arteriosclerotic nanoplaque formation and size in a biosensor model. Siegel G; Abletshauser C; Malmsten M; Klüssendorf D Biosens Bioelectron; 2003 May; 18(5-6):635-47. PubMed ID: 12706573 [TBL] [Abstract][Full Text] [Related]
6. [Inhibition of arteriosclerotic plaque development by garlic]. Siegel G; Michel F; Ploch M; Rodríguez M; Malmsten M Wien Med Wochenschr; 2004 Nov; 154(21-22):515-22. PubMed ID: 15638070 [TBL] [Abstract][Full Text] [Related]
7. Anionic biopolyelectrolytes of the syndecan/perlecan superfamily: physicochemical properties and medical significance. Siegel G; Malmsten M; Ermilov E Adv Colloid Interface Sci; 2014 Mar; 205():275-318. PubMed ID: 24534475 [TBL] [Abstract][Full Text] [Related]
8. Reduction of arteriosclerotic nanoplaque formation and size by fluvastatin in a receptor-based biosensor model. Siegel G; Abletshauser C; Malmsten M; Schmidt A; Winkler K Cardiovasc Res; 2003 Jun; 58(3):696-705. PubMed ID: 12798444 [TBL] [Abstract][Full Text] [Related]
9. Lipoprotein binding to anionic biopolyelectrolytes and the effect of glucose on nanoplaque formation in arteriosclerosis and Alzheimer's disease. Siegel G; Mockenhaupt FHME; Behnke AL; Ermilov E; Winkler K; Pries AR; Malmsten M; Hetzer R; Saunders R; Lindman B Adv Colloid Interface Sci; 2016 Jun; 232():25-35. PubMed ID: 26969281 [TBL] [Abstract][Full Text] [Related]
10. Effect of fish oil (n-3 polyunsaturated fatty acids) on plasma lipids, lipoproteins and inflammatory markers in HIV-infected patients treated with antiretroviral therapy: a randomized, double-blind, placebo-controlled study. Thusgaard M; Christensen JH; Mørn B; Andersen TS; Vige R; Arildsen H; Schmidt EB; Nielsen H Scand J Infect Dis; 2009; 41(10):760-6. PubMed ID: 19685375 [TBL] [Abstract][Full Text] [Related]
11. Towards biosensing of arteriosclerotic nanoplaque formation using femtosecond spectroscopy. Rodríguez M; Lindinger A; Ernsting NP; Malmsten M; Siegel G Arch Biochem Biophys; 2007 Apr; 460(1):92-9. PubMed ID: 17324375 [TBL] [Abstract][Full Text] [Related]
12. A receptor-based biosensor for lipoprotein docking at the endothelial surface and vascular matrix. Siegel G; Malmsten M; Klüssendorf D; Michel F Biosens Bioelectron; 2001 Dec; 16(9-12):895-904. PubMed ID: 11679268 [TBL] [Abstract][Full Text] [Related]
13. Increased plasma levels of tissue factor pathway inhibitor (TFPI) after n-3 polyunsaturated fatty acids supplementation in patients with chronic atherosclerotic disease. Berrettini M; Parise P; Ricotta S; Iorio A; Peirone C; Nenci GG Thromb Haemost; 1996 Mar; 75(3):395-400. PubMed ID: 8701396 [TBL] [Abstract][Full Text] [Related]
14. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia. Mackness MI; Bhatnagar D; Durrington PN; Prais H; Haynes B; Morgan J; Borthwick L Eur J Clin Nutr; 1994 Dec; 48(12):859-65. PubMed ID: 7889894 [TBL] [Abstract][Full Text] [Related]
15. Effects of oleic-rich and omega-3-rich diets on serum lipid pattern and lipid oxidation in mildly hypercholesterolemic patients. Puiggrós C; Chacón P; Armadans LI; Clapés J; Planas M Clin Nutr; 2002 Feb; 21(1):79-87. PubMed ID: 11884017 [TBL] [Abstract][Full Text] [Related]
16. Effects of marine n-3 fatty acid supplementation on lipoprotein subclasses measured by nuclear magnetic resonance in subjects with type II diabetes. Mostad IL; Bjerve KS; Lydersen S; Grill V Eur J Clin Nutr; 2008 Mar; 62(3):419-29. PubMed ID: 17327864 [TBL] [Abstract][Full Text] [Related]